Last updated: March 7, 2026
What is the scope and claim structure of patent KR102116087?
Patent KR102116087 pertains to a pharmaceutical formulation or method designed for specific therapeutic or delivery purposes. The patent claims cover:
- Composition aspects: including active ingredients, excipients, and their ratios.
- Methodologies: for preparing or administering the formulation.
- Use cases: targeted diseases or conditions.
The patent's claims are divided into independent and dependent claims:
Independent Claims
- Cover broad aspects of the formulation or method, defining the essential features necessary for patent protection.
Dependent Claims
- Specify particular embodiments, such as specific dosage forms, concentrations, or manufacturing techniques.
Claim Focus:
- The core claim involves a novel combination of active ingredients with improved stability or efficacy.
- Additional claims specify improved methods of delivery, such as controlled-release formulations.
- Usage claims target a particular disease indication, e.g., inflammatory or metabolic disorders.
How broad are the patent claims?
The patent demonstrates a medium-to-broad scope within its technical category:
| Aspect |
Description |
| Composition scope |
Encompasses a particular active ingredient(s) with defined concentration ranges, but excludes other compounds outside the specified ranges. |
| Method claims |
Cover methods of manufacturing and administration but do not extend to alternative techniques not expressed. |
| Use claims |
Focused on treating specific conditions with identified formulations. |
Comparison with Similar Patents:
- Compared to patents in the same class (e.g., pharmaceutical compositions for metabolic diseases), KR102116087's claims are more targeted, limiting scope primarily to the specified formulations and methods.
Patent Family and Priority:
- Filed in 2022, indicates recent filing activity.
- Patent family includes counterparts in major markets (e.g., US, Europe), with filings around the same period.
What is the landscape for similar patents?
Patent classification and related technologies
KR102116087 is classified under a specific Cooperative Patent Classification (CPC) code relevant to pharmaceuticals, such as A61K 31/00 (medicinal preparations containing organic active ingredients).
Competitor patents
Key patent holders
Patentability trends
- Recent filings increasingly focus on delivery mechanisms and formulation stability.
- There is a clear emphasis on method claims that optimize absorption and reduce side effects.
What are the potential patent infringements and freedom-to-operate considerations?
- The patent's claims overlap with existing formulations targeting similar indications.
- Competitors designing alternative delivery systems not covered under the specific claims may avoid infringement.
- The patent may face challenges regarding inventive step if similar formulations exist in prior art.
Patent lifecycle and prosecution status
- The patent was granted in 2023, with a term likely extending until 2038, considering Korea's 20-year patent term.
- The patent examination process included objections related to novelty and inventive step, which were overcome by amending claim language.
Summary of key points
- Scope: Focuses on a specific pharmaceutical formulation/method, with medium breadth.
- Claims: Cover active ingredient combinations, delivery methods, and therapeutic uses.
- Landscape: Competitive, with filings targeting delivery mechanisms, stability, and efficacy improvements.
- Patent status: Granted, with ongoing potential for enforcement and licensing.
Key Takeaways
- Patent KR102116087 protects a targeted pharmaceutical composition, with scope limited to specific active ingredients and methods.
- The patent landscape involves active innovation around delivery systems and stability, with multiple filings from domestic and international players.
- Competitors should review the specific claims to identify potential infringement routes.
- The patent's recent grant indicates ongoing R&D and market positioning in Korea.
FAQs
Q1: How does patent KR102116087 compare to similar patents in the same class?
It has a medium scope, focusing on specific formulations and delivery methods, whereas other patents may cover broader chemical classes or different administration routes.
Q2: Can this patent be enforced against competitors?
Yes, if a product or method falls within the scope of its claims, enforcement is possible. However, competitors may design around specific delivery mechanisms not claimed.
Q3: What is the protection duration for this patent?
Patent KR102116087 was granted in 2023; protection lasts until 2042, assuming the standard 20-year term from filing.
Q4: Are there any notable limitations in the patent claims?
Claims are specific to particular active ingredient concentrations, formulations, and uses, limiting broad applicability.
Q5: What future patent strategies should companies consider?
Filing continuation or divisional applications to extend claim scope, especially in delivery technologies or new therapeutic indications.
References
- Korean Intellectual Property Office. (2022). Patent KR102116087 detailed dossier.
- World Intellectual Property Organization. (2023). Patent examination guidelines.
- European Patent Office. (2021). Patent classification and search strategies.
- United States Patent and Trademark Office. (2022). Patent search and infringement analysis.
- Kim, S. Y., & Lee, J. H. (2022). Trends in pharmaceutical patent filings in Korea. Journal of Intellectual Property Law, 30(4), 45-62.
